Menu
Tchernof A, Després J-P. Pathophysiology of Human Visceral Obesity: An Update. Physiological Reviews. 2013;93(1):359-404.
Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & endocrinology. 2019;7(9):715-25.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9 ed. Washington2020.
Bendall CL, Mayr HL, Opie RS, Bes-Rastrollo M, Itsiopoulos C, Thomas CJ. Central obesity and the Mediterranean diet: A systematic review of intervention trials. Critical reviews in food science and nutrition. 2018;58(18):3070-84.
Ratjen I, Morze J, Enderle J, Both M, Borggrefe J, Müller HP, et al. Adherence to a plant-based diet in relation to adipose tissue volumes and liver fat content. Am J Clin Nutr. 2020;112(2):354-63.
Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, et al. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans who are Overweight: A Feasibility Study. Obesity (Silver Spring, Md). 2020;28(5):860-9.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. In: U.S. Department of Health and Human Services, editor. 2nd edition ed. Washington, DC,2018.
Maillard F, Pereira B, Boisseau N. Effect of High-Intensity Interval Training on Total, Abdominal and Visceral Fat Mass: A Meta-Analysis. Sports Medicine. 2018;48(2):269-88.
Van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral Fat: A Key Mediator of Steatohepatitis in Metabolic Liver Disease. Hepatology 2008;48(2):449-457.
Linge J, Borga M, West J, Tuthill T, Miller MR, Dumitriu A, et al. Body Composition Profiling in the UK Biobank Imaging Study. Obesity. 2018;26(11):1785-1795.
Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Després JP, Linge J, et al. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank. Mayo Clinic Proceedings. 2022;97(2);2256-237.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9 ed. Washington2020.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. In: U.S. Department of Health and Human Services, editor. 2nd edition ed. Washington, DC,2018.
Chait A, den Hartigh LJ. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Frontiers in Cardiovascular Medicine. 2020;7.
Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, et al. Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. The American journal of medicine. 2017;130(8):958-66.e1.
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2016;22 Suppl 3:1-203.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9 ed. Washington2020.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. In: U.S. Department of Health and Human Services, editor. 2nd edition ed. Washington, DC,2018.
Manne V, Handa P, Kowdley KV. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease. 2018;22(1):23-37.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.
Hydes TJ, Ravi S, Loomba R, E Gray M. Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clin Mol Hepatol. 2020;26(4):383-400.
Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. JAMA. 2020;323(12):1175-83.
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82-97.
van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expr. 2018;18(2):89-101.
Linge J, Borga M, West J, Tuthill T, Miller MR, Dumitriu A, et al. Body Composition Profiling in the UK Biobank Imaging Study. Obesity. 2018;26(11):1785-1795.
Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Després JP, Linge J, et al. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank. Mayo Clinic Proceedings. 2022;97(2);2256-237.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9 ed. Washington2020.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. In: U.S. Department of Health and Human Services, editor. 2nd edition ed. Washington, DC,2018.
Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia. Aging Research Reviews. 2021;70:101398.
Jiang Z, Marriott K, Maly MR. Impact of Inter- and Intramuscular Fat on Muscle Architecture and Capacity. Crit Rev Biomed Eng. 2019;47(6):515-33.
Hamrick MW, McGee-Lawrence ME, Frechette DM. Fatty Infiltration of Skeletal Muscle: Mechanisms and Comparisons with Bone Marrow Adiposity. Frontiers in endocrinology. 2016;7:69.
Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Frontiers in physiology. 2020;11:963.
Ramírez-Vélez R, Ezzatvar Y, Izquierdo M, García-Hermoso A. Effect of exercise on myosteatosis in adults: a systematic review and meta-analysis. Journal of Applied Physiology. 2021;130(1):245-55.
Shaw CS, Clark J, Wagenmakers AJ. The effect of exercise and nutrition on intramuscular fat metabolism and insulin sensitivity. Annu Rev Nutr. 2010;30:13-34.
B. EJ, Alaa A, C. MV. Role of n-3 fatty acids in muscle loss and myosteatosis. Applied Physiology, Nutrition, and Metabolism. 2014;39(6):654-62.
Ahmed S, Singh D, Khattab S, Babineau J, Kumbhare D. The Effects of Diet on the Proportion of Intramuscular Fat in Human Muscle: A Systematic Review and Meta-analysis. Frontiers in nutrition. 2018;5:7.
Linge J, Borga M, West J, Tuthill T, Miller MR, Dumitriu A, et al. Body Composition Profiling in the UK Biobank Imaging Study. Obesity. 2018;26(11):1785-1795.
Linge J, Heymsfield SB, Dahlqvist Leinhard O, On the Definition of Sarcopenia in the Presence of Aging and Obesity-Initial Results from UK Biobank. Journals of Gerontology: Medical Sciences. 2020;75(7):1309-1316.
Linge J, Ekstedt M, Dahlqvist Leinhard O, Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Reports. 2021;3(1):100197.
Linge J, Petersson M, Forgren MF, Sanyal AJ, Dahlqvist Leinhard O. Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study. Journal of Cachexia, Sarcopenia and Muscle 201;123:1513-1526.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9 ed. Washington2020.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. In: U.S. Department of Health and Human Services, editor. 2nd edition ed. Washington, DC,2018.
Prado CM, Purcell SA, Alish C, Pereira SL, Deutz NE, Heyland DK, et al. Implications of low muscle mass across the continuum of care: a narrative review. Annals of Medicine. 2018;50(8):675-93.
Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle. 2020;11(2):366-80.
Prado CM, Anker SD, Coats AJS, Laviano A, von Haehling S. Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire. Journal of cachexia, sarcopenia and muscle. 2021;12(1):3-8.
Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: A Time for Action. An SCWD Position Paper. Journal of cachexia, sarcopenia and muscle. 2019;10(5):956-61.
Phillips SM. A Brief Review of Critical Processes in Exercise-Induced Muscular Hypertrophy. Sports Medicine (Auckland, Nz). 2014;44(Suppl 1):71-7.
Lopez P, Radaelli R, Taaffe DR, Newton RU, Galvão DA, Trajano GS, et al. Resistance Training Load Effects on Muscle Hypertrophy and Strength Gain: Systematic Review and Network Meta-analysis. Medicine and science in sports and exercise. 2021;53(6):1206-16
Linge J, Heymsfield SB, Dahlqvist Leinhard O, On the Definition of Sarcopenia in the Presence of Aging and Obesity-Initial Results from UK Biobank. Journals of Gerontology: Medical Sciences. 2020;75(7):1309-1316.
Linge J, Ekstedt M, Dahlqvist Leinhard O, Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Reports. 2021;3(1):100197.
Linge J, Petersson M, Forgren MF, Sanyal AJ, Dahlqvist Leinhard O. Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study. Journal of Cachexia, Sarcopenia and Muscle 201;123:1513-1526.
Learn more about the science behind BCP.
Please visit amramedical.com
This web portal is intended as an educational resource. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.